Assignee
MENLO THERAPEUTICS INC
US·10 granted patents·2 pending applications·47 citations·filing 2014–2019
Top patents by PatentIndex Score
12 records- 0195US9737508B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·7 cites·31 claims
- 0295US9474741B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Oct 25, 2016·7 cites·22 claims
- 0394US9968588B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·5 cites·20 claims
- 0492US10278952B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·3 cites·32 claims
- 0592US9737507B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2016·Granted Aug 22, 2017·8 cites·31 claims
- 0689US9974769B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·5 cites·32 claims
- 0789US9486439B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2014·Granted Nov 8, 2016·7 cites·30 claims
- 0887US10617671B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2019·Granted Apr 14, 2020·1 cites·10 claims
- 0986US10278953B2Use of NK-1 receptor antagonist serlopitant in pruritusMENLO THERAPEUTICS INC·Filed 2018·Granted May 7, 2019·3 cites·31 claims
- 1082US10702499B2Use of NK-1 receptor antagonists in pruritusMENLO THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·1 cites·20 claims
- 1145US2018235931A1Use of neurokinin-1 antagonists as antitussivesMENLO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1237US2019216779A1Use of neurokinin-1 antagonists to treat a variety of pruritic conditionsMENLO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →